Role of Immune Checkpoint Inhibitors in Advanced or Recurrent Endometrial Cancer

Currently, treatment options for patients with advanced or recurrent endometrial cancer remain limited. The current standard of care treatment for advanced endometrial carcinoma is a platinum doublet chemotherapy. Second-line treatment options overall are very limited. There is no optimal treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Ena, Masab, Muhammad, Mittar, Priyanka, Jindal, Vishal, Gupta, Sorab, Dourado, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015998/
https://www.ncbi.nlm.nih.gov/pubmed/29942724
http://dx.doi.org/10.7759/cureus.2521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015998/
https://www.ncbi.nlm.nih.gov/pubmed/29942724
http://dx.doi.org/10.7759/cureus.2521

Ejemplares similares